Comparison of 21-gene assay and St.Gallen International Expert Consensus in the treatment decision for patients with early invasive breast cancers

This study aimed to evaluate the impacts of 21-gene recurrence score (RS) and St. Gallen International Expert Consensus on treatment decision and prognosis of patients with invasive breast cancer. We retrospectively analyzed the therapy protocol and outcome of 134 cases based on age, body mass index...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Ming, Li, Fu, Su, Ka, Yuan, Huiming, Zeng, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012076/
https://www.ncbi.nlm.nih.gov/pubmed/31663437
http://dx.doi.org/10.1080/15384047.2019.1669994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012076/
https://www.ncbi.nlm.nih.gov/pubmed/31663437
http://dx.doi.org/10.1080/15384047.2019.1669994

Ejemplares similares